We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-13.22%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.1B
AUM Growth
-$3.31B
Cap. Flow
-$374M
Cap. Flow %
-2.19%
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$53M
2
ATVI
Activision Blizzard
ATVI
+$52.3M
3
TTWO icon
Take-Two Interactive
TTWO
+$47.9M
4
EBAY icon
eBay
EBAY
+$44.3M
5
CAH icon
Cardinal Health
CAH
+$35.7M

Sector Composition

Rank Sector Weight
1 Technology 21.22%
2 Healthcare 14.4%
3 Financials 10.22%
4 Consumer Discretionary 8.43%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWI icon
576
iShares MSCI ACWI ETF
ACWI
$32.5B
$1.54M 0.01%
18,385
+5,006
+37% +$456K
VYMI icon
577
Vanguard International High Dividend Yield ETF
VYMI
$20.3B
$1.53M 0.01%
26,000
MTG icon
578
MGIC Investment
MTG
$6.34B
$1.51M 0.01%
120,096
+16
+0% +$210
APGB
579
DELISTED
Apollo Strategic Growth Capital II
APGB
$1.51M 0.01%
153,864
+30,000
+24% +$294K
LDHA
580
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$1.51M 0.01%
154,745
BAH icon
581
Booz Allen Hamilton
BAH
$8.59B
$1.51M 0.01%
16,729
-27,525
-62% -$2.35M
SKGRU
582
DELISTED
SK Growth Opportunities Corporation Unit
SKGRU
$1.5M 0.01%
+150,000
New +$1.49M
PPL
583
PPL Corp
PPL
$27.1B
$1.49M 0.01%
55,079
-230
-0.4% -$6.6K
NBIX icon
584
Neurocrine Biosciences
NBIX
$17.7B
$1.47M 0.01%
15,063
-1,750
-10% -$162K
NVT icon
585
nVent Electric
NVT
$24.1B
$1.46M 0.01%
46,727
+5,815
+14% +$198K
IBB icon
586
iShares Biotechnology ETF
IBB
$9.44B
$1.46M 0.01%
12,412
+4,180
+51% +$496K
HE icon
587
Hawaiian Electric Industries
HE
$2.28B
$1.46M 0.01%
35,635
-1,102
-3% -$46.3K
EXEL icon
588
Exelixis
EXEL
$14B
$1.44M 0.01%
68,930
+32,140
+87% +$662K
XYL icon
589
Xylem
XYL
$28.6B
$1.42M 0.01%
18,235
+3,535
+24% +$292K
XLP icon
590
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
$1.41M 0.01%
19,555
+570
+3% +$42.8K
DRI icon
591
Darden Restaurants
DRI
$23.4B
$1.41M 0.01%
12,461
+4,495
+56% +$561K
F icon
592
Ford
F
$58.5B
$1.38M 0.01%
124,503
+3,855
+3% +$52.8K
ELS icon
593
Equity Lifestyle Properties
ELS
$12.6B
$1.38M 0.01%
19,598
-28,292
-59% -$2.11M
HAL icon
594
Halliburton
HAL
$26.8B
$1.37M 0.01%
43,876
-4,874
-10% -$182K
EVRG icon
595
Evergy
EVRG
$19.8B
$1.37M 0.01%
21,066
+214
+1% +$14.5K
KVSC
596
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$1.37M 0.01%
140,418
FMC icon
597
FMC
FMC
$1.39B
$1.36M 0.01%
12,752
+765
+6% +$93.5K
BRSL
598
Brightstar Lottery PLC
BRSL
$1.93B
$1.36M 0.01%
73,525
-6,842
-9% -$146K
COLB icon
599
Columbia Banking Systems
COLB
$8.74B
$1.36M 0.01%
47,518
+183
+0.4% +$5.39K
VICI icon
600
VICI Properties
VICI
$29.5B
$1.35M 0.01%
45,371
-6,832
-13% -$201K

Similar funds

Glenmede Trust's Q2 2022 Portfolio in Review

As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
  • Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
  • Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
  • Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
  • Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
  • Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
  • Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.

Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.